Advances in research on Rotavin-M1
Abstract
“Rotavin-M1” is an oral live-attenuated vaccine that prevents diarrhea in children under five years old, produced from rotavirus strains G1P [1] on Vero cells. This vaccine has been studied for 16 years beginning with monitoring the local circulating strain and eventually establishing a seed lots system. The safety and immunogenicity of the vaccine were found equivalent to internationallyimported vaccines.
Keywords:
G1P, Rotavin-M1, vaccineDOI:
https://doi.org/10.31276/VJSTE.59(1).43Classification number
3.2

Downloads
Published
Received 23 December 2016; accepted 24 February 2017